Sponsors

C. difficile: the complete picture

Inverness Medical has introduced its new TECHLAB C. DIFF QUIK CHEK COMPLETE rapid test as an in vitro diagnostic aid for Clostridium difficileassociated disease (CDAD).

C. difficile is responsible for the most common form of hospitalacquired diarrhoea and antibioticassociated colitis. Although primarily a hospital-acquired disease, C. difficile infection is occurring increasingly in community out-patient settings. This is causing a major problem in hospitals and the community because the number of patients at risk of C. difficile infection is substantial. Highly infectious and extremely dangerous in the immunocompromised or elderly patient, C. difficile infection can be life threatening. The test provides results in less than 30 minutes from faecal samples, enabling rapid diagnosis and initiation of appropriate patient management. Patients can be isolated at an earlier stage, reducing the risk of crosscontamination and widespread outbreaks. In addition, the new TECHLAB C. DIFF QUIK CHEK COMPLETE test detects toxigenic and non-toxigenic strains, including the new hypervirulent C. difficile strain BI/NAP1/027 which is causing outbreaks of increasing severity and mortality across Europe and North America.

www.invernessmedical.com

Latest Issues

IHC Antibody Recognition & Expression Master Class

The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
4 August, 2026

IHC Technical Issues Master Class

The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
5 August, 2026

ECP 2026 - 38th European Congress of Pathology

Stockholmsmässan, Stockholm, Sweden
12-16 September, 2026

UK NEQAS Parasitology Symposium

UKHSA, 61 Colindale Avenue, London NW9 5EQ
18 September, 2026

UKHSA Conference 2026

Manchester Central, Manchester, M2 3GX
22-23 September, 2026